Trial Profile
Gleevec (Imatinib) Plus Multi-Agent Chemotherapy For Newly-Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Aug 2016
Price :
$35
*
At a glance
- Drugs Imatinib (Primary) ; Cytarabine; Daunorubicin; Etoposide; Folinic acid; Hydrocortisone; Methotrexate; Prednisolone; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 09 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Feb 2008 New trial record.